Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination

Withdrawn before enrolling · Not applicable

Conditions studied: Type 2 Diabetes

In brief

In this project the investigators seek to utilize our experience for developing a comprehensive informatics framework for rapid adaptation and dissemination of Comparative Effectiveness Research (CER) products tailored to different categories of health consumers including difficult-to-reach patients. Based on our previous successful experience in computer-assisted education, the investigators will refine the current CO-ED platform to implement and test a novel system for individualized continuous patient education (iCOPE). The iCOPE platform will be specifically designed to support rapid adaptation, customization, and dissemination of the CER products to the difficult-to-reach populations. The iCOPE platform will implement universal means for customized delivery of CER information in the format of interactive self-paced educational modules, quick "question \& answer" guides, and interactive decision aids. In addition, the iCOPE platform will support the innovative concept of continuous patient health education by providing patients with easy access to the interactive CER updates via web, MP3 players and phone-based interactive voice response (IVR) technology. Though iCOPE will be designed to support the whole spectrum of CER products, in this project the investigators will focus on the Comparative Effectiveness Research Summary Guide (CERSG) entitled "Pills for Type 2 Diabetes." The following primary hypothesis will be tested in the RCT: Use of the iCOPE platform will be associated with improvement in CERSG knowledge in elderly at 6 months after the intervention. The investigators will also examine the impact of iCOPE on medication adherence self-efficacy, diabetes medication satisfaction, HbA1c, and CERSG acceptance.

Key facts

Study ID

NCT01493258

Run by

Johns Hopkins University

People needed

0

Starts

2010-08-01

Last updated by the study team

2020-05-18

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• have clinical diagnosis of Type 2 diabetes;
• take oral diabetes medications;
• be 65 years of age or older at the time of randomization;
• plan to remain in the Maryland/DC area until the completion of the study follow-up;
• understand English at the 5th grade level.

You may not qualify if…

• plan to leave Maryland/DC area before the completion of the study follow- up;
• presence of significant cognitive impairment based on a Mini-Mental State Examination (MMSE) score ≤23
• do not speak English.

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States
• Johns Hopkins Bayview Medical Center — Baltimore, Maryland, United States
• Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.